Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and can be Targeted to Overcome Chemoresistance - ...

Justin Taylor, M.D., a physician-scientist at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller ...

The Utah father had been documenting his journey with cancer and the birth of his daughter after being first diagnosed at 25.

Colon cancer is the second leading cause of cancer-related deaths ... may indicate a tumor obstructing the colon. Pain persisting beyond a few days, especially if severe or worsening, should be ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Dr. Benjamin Weinberg, Associate Professor at Georgetown University and Principal Investigator of CytoDyn’s colorectal cancer (“CRC”) program, will present the Company’s clinical data at the ESMO ...

After losing Henry McCann to colorectal cancer at the age of 25, "Because of Henry" advocates for early-onset patients who ...

Program notes: 0:40 CAR-Ts for solid tumors. 1:40 Advanced gastric or gastroesophageal cancer. 2:40 Cytokine release syndrome. 3:22 Exercise after treatment for colorectal cancer. 4:23 Disease ...